Home›Stock Screener›Procter & Gamble Health

Procter & Gamble Health Share Price Today | Stock Price & Procter & Gamble Health Share Screener

PGHL Pharmaceuticals
Live Share Price NSE
₹5300.00
▼ -60.00 (-1.12%)
2026-10-05 00:00:00
Live Share Price BSE
₹5301.40
▼ -62.55 (-1.17%)
2026-10-05 00:00:00

As of October 5, 2026, the live Procter & Gamble Health share price (NSE: PGHL) is ₹5,300.00 on NSE and ₹5,301.40 on BSE, down 1.12% from the previous close, with shares trading between ₹5,280.00 and ₹5,403.50 in today's trading session, and a 52-week range of ₹4,778.60–₹6,918.50. Check PGHL 52-week high low for the annual price range and momentum. Use the Procter & Gamble Health stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Procter & Gamble Health opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹1,482 and net income of ₹357, with EBITDA of ₹515, an operating margin of 33.0% and a profit margin of 24.1%.

Procter & Gamble Health Market Cap ₹8,897.27 Cr.
PGHL P/E Ratio (TTM) 25.87
Procter & Gamble Health P/B Ratio 17.60
EPS (TTM) ₹197.00
Dividend Yield 3.69%
Debt to Equity 0.02
PGHL 52 Week High ₹6918.50
Procter & Gamble Health 52 Week Low ₹4778.60
Operating Margin 33.00%
Profit Margin 24.09%
PGHL Revenue (TTM) ₹1,482.00
EBITDA ₹515.00
Net Income ₹357.00
Total Assets ₹841.00
Total Equity ₹525.00

Procter & Gamble Health Share Price Chart

Track the current stock price of Procter & Gamble Health with an interactive chart. Analyse PGHL share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Procter & Gamble Health stock quote in one place.

The quote of ₹5,300.00 sits between the 52-week low of ₹4,778.60 and the 52-week high of ₹6,918.50, and the latest session moved -1.12% from the previous close.

Procter & Gamble Health Company Profile - Fundamental Screener

Screen Procter & Gamble Health company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for PGHL shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE199A01012.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE199A01012

Procter & Gamble Health Balance Sheet Screener

Screen PGHL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹841, up from ₹794 in 2025.

Latest statistics put total assets at ₹841 and shareholder funds at ₹525, with a leverage ratio of 0.02.

Item 2026 2025 2024 2023 2022 2021 2020 2018 2017 2016

Assets

Total Assets 841 794 794 1,101 888 986 1,176 1,760 991 879
Current Assets 556 526 524 796 608 727 954 1,534 752 636
Fixed Assets 102 116 129 144 112 104 101 104 115 111

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 62 42 37 46 40 44 42 27 33 29
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 525 537 538 751 617 704 906 1,540 733 664
Share Capital 17 17 17 17 17 17 17 17 17 17
Reserves & Surplus 508 520 522 734 600 687 890 1,524 717 647

Procter & Gamble Health Income Statement Screener - Profit & Revenue Analysis

Screen Procter & Gamble Health income statement and profit fundamentals. Analyze PGHL quarterly results. Procter & Gamble Health reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹1,482 and net profit was ₹357, equal to earnings per unit of ₹215.00, at an operating margin of 33%.

In that period expenses were ₹967, interest cost ₹1 and tax ₹127. The next period listed, 2026-March, shows revenue of ₹1,425 and net profit of ₹327.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 1,482 1,425 945 1,167 1,248 1,128 1,027 1,425 873 722 1,017 963
Expenses 967 951 616 845 905 847 763 1,041 701 621 877 856

Operating Costs and Margins

EBITDA 515 474 329 322 343 281 264 384 173 101 140 107
Operating Profit % 33.00% 32.00% 34.00% 27.00% 26.00% 24.00% 24.00% 23.00% 17.00% 11.00% 12.00% 9.00%
Depreciation 24 24 17 27 28 27 30 30 21 19 25 23
Interest 1 1 0 1 1 0 1 0 0 0 0 0

Profit and Earnings

Profit Before Tax 490 450 312 273 314 253 233 355 158 99 115 83
Tax 127 123 77 72 85 61 57 101 56 38 36 30
Net Profit 357 327 234 201 230 193 177 254 102 61 79 54
EPS 215.00 197.00 141.00 121.00 138.00 116.00 107.00 153.00 505.27 56.60 47.70 32.30

Procter & Gamble Health Cash Flow Screener - Liquidity Fundamentals

Screen PGHL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹338, and net cash flow was an outflow of ₹5.

Over the same period, investing activities provided ₹1 and financing activities used ₹344.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2018-March 2017-March 2016-March

Cash from Operations and Investing

Operating Activities 338 169 228 236 170 247 235 -130 54 107
Investing Activities 1 10 -7 -22 -26 -32 165 1,270 -48 -75

Financing and Net Cash

Financing Activities -344 -235 -418 -99 -289 -387 -883 -30 -22 -15
Net Cash Flow -5 -57 -197 116 -145 -172 -483 1,109 -16 17

Procter & Gamble Health Shareholding Pattern Screener

See Procter & Gamble Health shareholding pattern with promoter, FII, and DII holdings. Check Procter & Gamble Health promoter holding and ownership changes for PGHL on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 51.82%, foreign institutions 6.20%, domestic institutions 13.68% and the public 23.17%, spread across 50,883 shareholders.

The shareholder count was 50,883 in 2026-Mar, compared with 49,056 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 51.82% 51.82% 51.82% 51.82% 51.82% 51.82% 51.82% 51.82%

Institutional Investors

FII Holding 6.20% 6.33% 6.87% 6.99% 7.24% 6.97% 6.24% 6.40%
DII Holding 13.68% 12.44% 14.21% 14.16% 13.91% 13.84% 13.73% 14.55%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 23.17% 23.56% 21.90% 21.89% 22.15% 22.43% 22.61% 21.82%
Other Holding 5.14% 5.85% 5.21% 5.14% 4.89% 4.94% 5.60% 5.41%
Shareholder Count 50,883 49,056 53,993 52,478 50,006 49,302 56,778 55,923

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Procter & Gamble Health. Procter & Gamble Health dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹205.00 per unit for 2026-March, a yield of 3.82%, compared with ₹125.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹205.00, ₹125.00 and ₹260.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹205.00 3.82%
2025-March ₹125.00 2.60%
2024-March ₹260.00 5.05%
2023-March ₹95.00 2.02%
2022-March ₹52.50 1.12%
2021-March ₹130.00 3.25%
2020-March ₹230.00 3.71%
2019-March ₹0.00 0.00%
2018-March ₹440.00 11.91%
2017-March ₹15.00 1.00%

Procter & Gamble Health Stock Index Membership - Nifty & Sensex

See which indices include Procter & Gamble Health stock. Check PGHL index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 6 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX BSE500, BSE INDEX MSL400.

Complete Index List

BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP

Procter & Gamble Health Market Events Screener - Corporate Actions

Get Procter & Gamble Health corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Procter & Gamble Health stock events that may affect PGHL share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 2, 2026, with a record date of November 2, 2026.

It is followed by Annual General Meeting dated September 3, 2026 and Dividend dated August 27, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-02 2026-11-02 Quarterly Result Announcement NA -6.17%
2026-09-03 2026-09-03 Annual General Meeting NA -0.74%
2026-08-27 2026-08-27 Dividend ₹ 45.00 /share 0.78%
2026-08-06 2026-08-06 Quarterly Result Announcement NA 3.50%
2026-05-26 2026-05-26 Quarterly Result Announcement NA 15.83%
2026-02-12 2026-02-12 Dividend ₹ 50.00 /share 4.56%
2026-02-12 2026-02-12 Dividend ₹ 110.00 /share 4.56%
2026-02-06 2026-02-06 Quarterly Result Announcement NA -6.98%
2025-11-05 2025-11-05 Quarterly Result Announcement NA -3.34%
2025-08-29 2025-08-29 Annual General Meeting NA 1.83%
2025-08-22 2025-08-22 Dividend ₹ 45.00 /share 10.63%
2025-08-01 2025-08-01 Quarterly Result Announcement NA 0.33%
2025-05-29 2025-05-29 Quarterly Result Announcement NA 5.91%
2025-02-21 2025-02-21 Dividend ₹ 80.00 /share 1.63%
2025-02-12 2025-02-12 Quarterly Result Announcement NA -3.43%

Procter & Gamble Health Competitors Screener - Peer Stocks Comparison

Screen PGHL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 432,120 36.04 61,674 12.69% 11,565 36.68
Divis Laboratories 245,532 84.24 11,067 13.95% 2,568 51.70
Torrent Pharmaceuticals 181,333 84.71 13,886 20.34% 2,138 41.12
Zydus Life Science 114,284 25.27 27,658 17.64% 5,026 47.64
Cipla 108,576 32.50 29,045 2.24% 3,870 34.78
Laurus Labs 107,198 98.20 6,868 22.01% 890 58.70
Mankind Pharma 104,707 50.04 14,636 14.85% 1,938 61.75
Dr Reddys Laboratories 100,679 32.41 35,059 3.90% 4,158 53.84
Aurobindo Pharma 96,479 25.84 34,145 5.56% 3,503 50.30
Lupin 92,885 16.82 29,039 26.75% 5,356 31.59

Procter & Gamble Health Company Announcements - News & Reports Screener

Screen PGHL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 2, 2026.

The next most recent announcements are dated September 27, 2026 and September 18, 2026.

Date Update Actions
2026-10-02 Board Meeting Intimation for Intimation Of Board Meeting -
2026-09-27 Closure of Trading Window -
2026-09-18 Intimation Regarding Ease Of Doing Investment - Special Window For Transfer And Dematerialization -
2026-09-04 Re-Appointment Of Mr. S. Madhavan As Independent Director Of The Company. -
2026-09-04 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-03 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-12 59Th Annual General Meeting Of The Company -
2026-08-12 Business Responsibility and Sustainability Reporting (BRSR) -
2026-08-12 Reg. 34 (1) Annual Report. -
2026-08-12 Notice Calling The 59Th Annual General Meeting Of The Company. -
2026-08-10 Record Date For Purpose Of Dividend -
2026-08-06 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-08-06 Unaudited Financial Results For The Quarter Ended June 30 2026 -
2026-08-06 Board Meeting Outcome for Outcome Of Board Meeting -
2026-07-15 Update Regarding CompanyS Annual General Meeting For The Financial Year 2025-26 And Record Date -
2026-07-03 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-26 Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Health Limited (The Company) -
2026-06-26 Closure of Trading Window -
2026-06-26 Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On August 6 2026 -
2026-06-25 Announcement under Regulation 30 (LODR)-Change in Management -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹5,300.00, within a 52-week range of ₹4,778.60 to ₹6,918.50. The P/E ratio is 25.87 and the P/B ratio is 17.60, with earnings per unit of ₹197.00. Market capitalisation stands at ₹8,897.27 Cr and the dividend yield is 3.69%. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 5, 2026. This page covers 10 balance sheet periods, 12 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.